Sera Prognostics Inc. Class A Company Profile
NASDAQ: SERAHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Sera Prognostics at a glance
Sera Prognostics Inc. Class A (NASDAQ: SERA) is a Medical Specialities company in the Health Care sector headquartered in Salt Lake City, UT. Sera Prognostics is led by Ms. Zhenya Lindgardt M.B.A. and employs about 71 people. The company's shares have traded publicly since 2021.
At a market capitalization of $72.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001534969, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Sera Prognostics do?
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Business description based on the company's public filings.
Company information
- Legal name
- Sera Prognostics Inc. Class A
- Ticker
- NASDAQ: SERA
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Ms. Zhenya Lindgardt M.B.A.
- Employees
- 71
- Headquarters
- 2749 East Parleys Way, Salt Lake City, UT, United States
- Phone
- 801 990 0520
- Website
- sera.com
- IPO year
- 2021
- Market cap
- $71.98M
- SEC CIK
- 0001534969
- Latest annual report
- 10-K · Mar 18, 2026
Companies similar to Sera Prognostics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BDSXBiodesix Inc. | 7.56 | -8.92% | $83.83M | vs SERA |
| XGNExagen Inc. | 3.61 | -5.00% | $92.10M | vs SERA |
| KEQUKewaunee Scientific Corporation | 33.55 | -2.75% | $97.14M | vs SERA |
| MDXHMDxHealth SA | 0.1074 | -8.52% | $10.25M | vs SERA |
| AMSAmerican Shared Hospital Services | 1.00 | -4.76% | $6.67M | vs SERA |
| BNRBurning Rock Biotech Limited ADR | 13.24 | -0.60% | $139.63M | vs SERA |
| ACONAclarion Inc. | 1.22 | -13.92% | $3.52M | vs SERA |
| ADVBAdvanced Biomed Inc. | 1.65 | -5.71% | $2.73M | vs SERA |